首页 > 最新文献

Endocrine and Metabolic Science最新文献

英文 中文
Estimate incidence and predictive factors of pediatric central diabetes insipidus in a single-institute study 单机构研究中儿童中枢性尿崩症发病率和预测因素的估计
Q3 Medicine Pub Date : 2022-06-30 DOI: 10.1016/j.endmts.2022.100119
Miyuki Kitamura, Junko Nishioka, Takako Matsumoto, Satoko Umino, Atsuko Kawano, Reo Saiki, Yukari Tanaka, Shuichi Yatsuga

Objective

This study provided a rough estimate incidence of primary pediatric central diabetes insipidus (CDI) and examines the diagnostic factors between pediatric CDI and primary polydipsia (PP).

Methods

We collected 27 patients with chief complaints of polyuria and/or polydipsia from January 2014 to December 2018 in the Department of Pediatrics, Our University Hospital.

Results

We diagnosed type 1 diabetes mellitus (T1DM) in 16 patients, CDI in 5, PP in 5, and nocturnal enuresis in 1. The rough estimate incidence rate of pediatric CDI was 0.71/100,000/year. The diagnostic factors were a body mass index (BMI), urine gravity in the morning, urine volume and intake volume over 24 h, and bright spots in the posterior pituitary in a magnetic resonance image (MRI). The cutoff value of urine gravity in the morning for CDI was <1.010, with a sensitivity of 100 % and specificity of 100 %. The cutoff value of urine volume over 24 h for CDI was >2299 mL/m2, with a sensitivity of 100 % and specificity of 85.7 %. No pediatric CDI patients had the bright spot in the posterior pituitary of their MRI, using a type 1–weighted image; however, only 1 out of 4 PP patients did not show the bright spot.

Conclusion

The rough estimate incidence of pediatric CDI with polydipsia and polyuria under the limited condition was 0.71/100,000/year, which was very low. Distinguishable factors between CDI patients and PP patients were BMI, urine and intake volumes over 24 h, and a bright spot on an MRI. Further studies with multiple institutes and more patients are required to confirm these findings.

目的初步估计小儿原发性中枢性尿崩症(CDI)的发病率,探讨小儿CDI与原发性多饮(PP)之间的诊断因素。方法收集2014年1月至2018年12月在我院儿科以多尿和/或烦渴为主诉的患者27例。结果16例诊断为1型糖尿病(T1DM), 5例诊断为CDI, 5例诊断为PP, 1例诊断为夜间遗尿。粗略估计儿童CDI发病率为0.71/10万/年。诊断因素为体重指数(BMI)、晨尿重力、尿量和摄食量大于24 h、磁共振成像(MRI)垂体后叶亮斑。晨尿重力诊断CDI的临界值为1.010,敏感性为100% %,特异性为100% %。尿量大于24 h诊断CDI的临界值为2299 mL/m2,敏感性为100% %,特异性为85.7% %。使用1型加权图像,没有儿童CDI患者的MRI在垂体后叶出现亮点;然而,只有1 / 4的PP患者没有出现亮点。结论限定条件下小儿CDI伴多饮多尿的发生率粗略估计为0.71/10万/年,很低。CDI患者和PP患者之间的可区分因素是BMI、尿液和超过24 h的摄入量,以及MRI上的亮点。进一步的研究需要多个研究所和更多的患者来证实这些发现。
{"title":"Estimate incidence and predictive factors of pediatric central diabetes insipidus in a single-institute study","authors":"Miyuki Kitamura,&nbsp;Junko Nishioka,&nbsp;Takako Matsumoto,&nbsp;Satoko Umino,&nbsp;Atsuko Kawano,&nbsp;Reo Saiki,&nbsp;Yukari Tanaka,&nbsp;Shuichi Yatsuga","doi":"10.1016/j.endmts.2022.100119","DOIUrl":"10.1016/j.endmts.2022.100119","url":null,"abstract":"<div><h3>Objective</h3><p>This study provided a rough estimate incidence of primary pediatric central diabetes insipidus (CDI) and examines the diagnostic factors between pediatric CDI and primary polydipsia (PP).</p></div><div><h3>Methods</h3><p>We collected 27 patients with chief complaints of polyuria and/or polydipsia from January 2014 to December 2018 in the Department of Pediatrics, Our University Hospital.</p></div><div><h3>Results</h3><p>We diagnosed type 1 diabetes mellitus (T1DM) in 16 patients, CDI in 5, PP in 5, and nocturnal enuresis in 1. The rough estimate incidence rate of pediatric CDI was 0.71/100,000/year. The diagnostic factors were a body mass index (BMI), urine gravity in the morning, urine volume and intake volume over 24 h, and bright spots in the posterior pituitary in a magnetic resonance image (MRI). The cutoff value of urine gravity in the morning for CDI was &lt;1.010, with a sensitivity of 100 % and specificity of 100 %. The cutoff value of urine volume over 24 h for CDI was &gt;2299 mL/m<sup>2</sup>, with a sensitivity of 100 % and specificity of 85.7 %. No pediatric CDI patients had the bright spot in the posterior pituitary of their MRI, using a type 1–weighted image; however, only 1 out of 4 PP patients did not show the bright spot.</p></div><div><h3>Conclusion</h3><p>The rough estimate incidence of pediatric CDI with polydipsia and polyuria under the limited condition was 0.71/100,000/year, which was very low. Distinguishable factors between CDI patients and PP patients were BMI, urine and intake volumes over 24 h, and a bright spot on an MRI. Further studies with multiple institutes and more patients are required to confirm these findings.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666396122000024/pdfft?md5=6d56435645bbeb2b8e39a0a5a3ef27b5&pid=1-s2.0-S2666396122000024-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44762898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effect of nutritional supplementation of zinc-sulfate against cisplatin-induced spermatogonial and testicular dysfunctions in adult male Sprague-Dawley rats 营养补充硫酸锌对顺铂诱导成年雄性Sprague-Dawley大鼠精原细胞和睾丸功能障碍的保护作用
Q3 Medicine Pub Date : 2022-03-31 DOI: 10.1016/j.endmts.2021.100116
Sunday Aderemi Adelakun , Babatunde Ogunlade , Obinna Peter Fidelis , Olusegun Dare Omotoso

Zinc (Zn) has proven to play a key role in spermatogenesis. The present study focused on the nutritional supplementation of Zn against cisplatin (CP)-induced spermatogonial and testicular dysfunctions.

Thirty-two (32) mature male Sprague Dawley rats were randomized into four groups of eight (n = 8) rats each – Control group (received 2 ml of normal saline); Zn group (received 1 mg/kg body weight (bwt) of Zn sulfate); Cisplatin group treated intraperitoneally with a single dose (10 mg/kg bwt) of CP; and CP + Zn group, after induction of testicular toxicity, were treated (orally) with 1 mg/kg bwt of Zn sulfate. The procedure lasted for 8 weeks. Parameters tested include testicular histology, sperm parameters, testosterone (TT), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), catalase (CAT), superoxide dismutase (SOD), peroxidase (POD), glutathione reductase (GR), thiobarbituric acid reactive substances (TBARS).

Cisplatin significantly decreases (p < 0.05) sperm quality, testosterone, FSH and LH, epithelial cell height, tubular diameter, number of spermatogonia, spermatocytes, and spermatids with concomitant increase in thiobarbituric acid reactive substances (TBARS). Zinc supplementation reversed the toxic effect of CP on sperm characterization, hormone profiling, histological and biochemical parameters.

Zinc supplementation, therefore, ameliorates the deleterious effect of CP on cytoarchitecture of the testis, protected the seminiferous epithelium, and reduced oxidative stress thereby promoting spermatogenesis.

锌(Zn)已被证明在精子发生中起着关键作用。本研究的重点是营养补充锌对顺铂(CP)诱导的精原和睾丸功能障碍的影响。将32只成年雄性Sprague Dawley大鼠随机分为4组,每组8只(n = 8只)。对照组(给予生理盐水2 ml);锌组(给予1 mg/kg体重硫酸锌);顺铂组腹腔注射单剂量CP(10 mg/kg bwt);CP + 锌组在诱导睾丸毒性后,口服硫酸锌1 mg/kg bwt。整个过程持续了8 周。检测参数包括睾丸组织学、精子参数、睾酮(TT)、促卵泡激素(FSH)、促黄体生成素(LH)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、过氧化物酶(POD)、谷胱甘肽还原酶(GR)、硫代巴比妥酸活性物质(TBARS)。顺铂显著降低(p < 0.05)精子质量、睾酮、FSH和LH、上皮细胞高度、小管直径、精原细胞、精母细胞和精母细胞数量,同时硫代巴比妥酸反应性物质(TBARS)增加。锌补充剂逆转了CP对精子特征、激素谱、组织学和生化参数的毒性作用。因此,补充锌可以改善CP对睾丸细胞结构的有害影响,保护精系上皮,减少氧化应激,从而促进精子发生。
{"title":"Protective effect of nutritional supplementation of zinc-sulfate against cisplatin-induced spermatogonial and testicular dysfunctions in adult male Sprague-Dawley rats","authors":"Sunday Aderemi Adelakun ,&nbsp;Babatunde Ogunlade ,&nbsp;Obinna Peter Fidelis ,&nbsp;Olusegun Dare Omotoso","doi":"10.1016/j.endmts.2021.100116","DOIUrl":"10.1016/j.endmts.2021.100116","url":null,"abstract":"<div><p>Zinc (Zn) has proven to play a key role in spermatogenesis. The present study focused on the nutritional supplementation of Zn against cisplatin (CP)-induced spermatogonial and testicular dysfunctions.</p><p>Thirty-two (32) mature male Sprague Dawley rats were randomized into four groups of eight (n = 8) rats each – Control group (received 2 ml of normal saline); Zn group (received 1 mg/kg body weight (bwt) of Zn sulfate); Cisplatin group treated intraperitoneally with a single dose (10 mg/kg bwt) of CP; and CP + Zn group, after induction of testicular toxicity, were treated (orally) with 1 mg/kg bwt of Zn sulfate. The procedure lasted for 8 weeks. Parameters tested include testicular histology, sperm parameters, testosterone (TT), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), catalase (CAT), superoxide dismutase (SOD), peroxidase (POD), glutathione reductase (GR), thiobarbituric acid reactive substances (TBARS).</p><p>Cisplatin significantly decreases (p &lt; 0.05) sperm quality, testosterone, FSH and LH, epithelial cell height, tubular diameter, number of spermatogonia, spermatocytes, and spermatids with concomitant increase in thiobarbituric acid reactive substances (TBARS). Zinc supplementation reversed the toxic effect of CP on sperm characterization, hormone profiling, histological and biochemical parameters.</p><p>Zinc supplementation, therefore, ameliorates the deleterious effect of CP on cytoarchitecture of the testis, protected the seminiferous epithelium, and reduced oxidative stress thereby promoting spermatogenesis.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266639612100039X/pdfft?md5=d4a4c3bdcea49ee7c672a26f6821a50c&pid=1-s2.0-S266639612100039X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43242819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Errata for Editorial Disclosures 编辑披露的勘误表
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100111
{"title":"Errata for Editorial Disclosures","authors":"","doi":"10.1016/j.endmts.2021.100111","DOIUrl":"https://doi.org/10.1016/j.endmts.2021.100111","url":null,"abstract":"","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100111","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137241042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative studies on nutrient content and antidiabetic effects of sugar palm (Borassus flabellifer) fruit pulp & endosperm on rats 糖棕榈果肉及胚乳对大鼠营养成分及抗糖尿病作用的比较研究
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100113
Shaikh Shahinur Rahman, Shubho Nanda Chowdhury, Md. Salauddin, Zubaer Hosen, Md. Rezaul Karim, Shakh MA. Rouf

Nutrient contents of sugar palm (Borassus flabellifer) fruit pulp (SPFP) cultivated in Bangladesh are yet to be well-reviewed. Moreover, the nutrient contents of other popularly consumed edible portions of sugar palm fruit, i.e., immature endosperm (IE), and germinated endosperm (GE) are not studied yet. The current study showed that SPFP, IE, and GE were rich in carbohydrate, fiber, sodium, potassium, and zinc. IE contained the highest amount of fiber, while SPFP contained the highest amount of copper. Twenty-five phytochemicals having known antidiabetic effects were investigated for their presence in pulp, immature & germinated endosperm. GE contained the highest number of phytochemicals (23) followed by IE (19) and SPFP (14). Diabetic patients usually avoid edible portions of sugar palm, fearing that these may further deteriorate existing hyperglycemia. In the present study, this suspicion was investigated in alloxan-induced diabetic rats through supplementary feeding of SPFP, IE, & GE in addition to the regular diet for the nine consecutive weeks. Study results clearly showed that SPFP, IE, & GE significantly reduced fasting blood glucose (FBG) levels of experimental rats. GE showed maximum antidiabetic effects followed by IE and SPFP, respectively. GE, and IE returned the FBG levels within normal range by the end of the sixth week but not by the SPFP. Endosperms supplemented diabetic rats maintained the normal FBG levels even after withdrew the supplementary diets. These results suggested that supplemental feeding of the GE and IE to the experimental diabetic rats may restore alloxan damaged pancreatic β-cell function, and the reasons might be the presence of fiber, zinc and phytochemicals content of the endosperm.

在孟加拉国种植的糖棕榈(Borassus flabellifer)果肉(SPFP)的营养成分尚未得到很好的评价。此外,糖棕榈果实的其他常见食用部分,即未成熟胚乳(IE)和发芽胚乳(GE)的营养成分尚未研究。目前的研究表明,SPFP、IE和GE富含碳水化合物、纤维、钠、钾和锌。IE中纤维含量最高,而SPFP中铜含量最高。研究了25种已知具有抗糖尿病作用的植物化学物质在牙髓、未成熟和未成熟中的存在。发芽胚乳。GE含有最多的植物化学物质(23),其次是IE(19)和SPFP(14)。糖尿病患者通常避免食用糖棕榈的部分,担心这些可能会进一步恶化现有的高血糖。本研究在四氧嘧啶诱导的糖尿病大鼠中,通过补充SPFP、IE、&在常规饮食的基础上进行连续9周的GE试验。研究结果清楚地表明,SPFP、IE、&GE显著降低实验大鼠空腹血糖(FBG)水平。GE的降糖作用最大,IE次之,SPFP次之。GE和IE在第六周结束时将FBG水平恢复到正常范围内,但SPFP没有。补充胚乳的糖尿病大鼠在停止补充饮食后仍能维持正常的空腹血糖水平。上述结果提示,添加GE和IE可使实验性糖尿病大鼠四氧嘧啶损伤的胰腺β细胞功能恢复,其原因可能与胚乳中纤维、锌和植物化学物质含量的存在有关。
{"title":"Comparative studies on nutrient content and antidiabetic effects of sugar palm (Borassus flabellifer) fruit pulp & endosperm on rats","authors":"Shaikh Shahinur Rahman,&nbsp;Shubho Nanda Chowdhury,&nbsp;Md. Salauddin,&nbsp;Zubaer Hosen,&nbsp;Md. Rezaul Karim,&nbsp;Shakh MA. Rouf","doi":"10.1016/j.endmts.2021.100113","DOIUrl":"10.1016/j.endmts.2021.100113","url":null,"abstract":"<div><p>Nutrient contents of sugar palm (Borassus flabellifer) fruit pulp (SPFP) cultivated in Bangladesh are yet to be well-reviewed. Moreover, the nutrient contents of other popularly consumed edible portions of sugar palm fruit, i.e., immature endosperm (IE), and germinated endosperm (GE) are not studied yet. The current study showed that SPFP, IE, and GE were rich in carbohydrate, fiber, sodium, potassium, and zinc. IE contained the highest amount of fiber, while SPFP contained the highest amount of copper. Twenty-five phytochemicals having known antidiabetic effects were investigated for their presence in pulp, immature &amp; germinated endosperm. GE contained the highest number of phytochemicals (23) followed by IE (19) and SPFP (14). Diabetic patients usually avoid edible portions of sugar palm, fearing that these may further deteriorate existing hyperglycemia. In the present study, this suspicion was investigated in alloxan-induced diabetic rats through supplementary feeding of SPFP, IE, &amp; GE in addition to the regular diet for the nine consecutive weeks. Study results clearly showed that SPFP, IE, &amp; GE significantly reduced fasting blood glucose (FBG) levels of experimental rats. GE showed maximum antidiabetic effects followed by IE and SPFP, respectively. GE, and IE returned the FBG levels within normal range by the end of the sixth week but not by the SPFP. Endosperms supplemented diabetic rats maintained the normal FBG levels even after withdrew the supplementary diets. These results suggested that supplemental feeding of the GE and IE to the experimental diabetic rats may restore alloxan damaged pancreatic β-cell function, and the reasons might be the presence of fiber, zinc and phytochemicals content of the endosperm.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666396121000364/pdfft?md5=11c6514f93007bcbe1854eba524082ec&pid=1-s2.0-S2666396121000364-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43446446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID–19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use COVID-19和孕激素:第2部分。揭示高严重性,免疫模式,免疫分级,黄体酮及其潜在的临床应用
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100110
Shilpa Bhuaptrai Shah

Severely ill COVID–19 (Corona Virus Disease of 2019) patients have a hyperinflammatory condition with a high concentration of pro-inflammatory cytokines termed the cytokine storm. This milieu is reported to cause acute lung injury, oxygen deprivation, multiorgan damage, critical illness, and often death. Post SARS–CoV–2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection, the fight between the invading virus and the host's immune system would either terminate in recovery, with eradication of the infection and regulation of the immune system; or there would be a continuation of immune attacks even after the virus has been cleared, leading to immune dysregulation and disease. This outcome is chiefly dependent on two factors: (1) the patient's immune response, and (2) sufficiency plus efficiency of the regulator(s). Concerning the first, the present research introduces a framework based on different types of immune responses to SARS–CoV–2 along with known disease examples, and how this relates to varying clinical outcomes and treatment needs for COVID–19 patients. About the second factor of ‘regulator(s)’, part 1 of the manuscript described in depth the regulatory role of progesterone in COVID–19. The present study investigates five immunity patterns and the status of the regulatory hormone progesterone with respect to the two established demographic risk factors for COVID–19 high-severity: male sex, and old age. The study evaluates the status of progesterone as a credible determinant of immune regulation and dysregulation. It duly relates the immunity patterns to clinical outcomes and evinces indications for clinical use of progesterone in COVID–19. It proposes a clear answer to the question: "why are males and old patients most likely to have critical illness due to COVID–19?" The study highlights clinical domains for the use of progesterone in COVID–19. Part 2 of this research introduces the concept of immunity patterns and immunity grading. These concepts herewith provided for the clinical course of COVID–19 also apply to other hyperinflammatory conditions. Possible clinical applications of progesterone to treat critically ill COVID–19 patients will open an avenue for hormonal treatments of infections and other immune-related diseases.

重症COVID-19(2019年冠状病毒病)患者具有高炎症状态,具有高浓度的促炎细胞因子,称为细胞因子风暴。据报道,这种环境会导致急性肺损伤、缺氧、多器官损伤、危重疾病,并经常导致死亡。在SARS-CoV-2(严重急性呼吸综合征冠状病毒2)感染后,入侵病毒与宿主免疫系统之间的斗争要么在恢复中终止,随着感染的根除和免疫系统的调节;或者,即使在病毒被清除后,免疫攻击仍会继续,导致免疫失调和疾病。该结果主要取决于两个因素:(1)患者的免疫反应,(2)调节因子的充分性和效率。关于第一点,本研究介绍了一个基于对SARS-CoV-2的不同类型免疫反应以及已知疾病示例的框架,以及这与COVID-19患者不同临床结果和治疗需求的关系。关于第二个因素“调节剂”,手稿的第1部分深入描述了孕酮在COVID-19中的调节作用。本研究调查了五种免疫模式和调节激素孕酮在COVID-19高严重程度的两个既定人口危险因素(男性和老年)中的地位。该研究评估了黄体酮作为免疫调节和失调的可靠决定因素的地位。它将免疫模式与临床结果和COVID-19临床使用黄体酮的适应症适当地联系起来。它为“为什么男性和老年患者最容易因COVID-19而患上危重疾病”这个问题提供了明确的答案?该研究强调了在COVID-19中使用黄体酮的临床领域。本研究的第二部分介绍了免疫模式和免疫分级的概念。本文为COVID-19临床病程提供的这些概念也适用于其他高炎症性疾病。孕酮在COVID-19危重症患者中的潜在临床应用,将为感染和其他免疫相关疾病的激素治疗开辟一条道路。
{"title":"COVID–19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use","authors":"Shilpa Bhuaptrai Shah","doi":"10.1016/j.endmts.2021.100110","DOIUrl":"10.1016/j.endmts.2021.100110","url":null,"abstract":"<div><p>Severely ill COVID–19 (Corona Virus Disease of 2019) patients have a hyperinflammatory condition with a high concentration of pro-inflammatory cytokines termed the cytokine storm. This milieu is reported to cause acute lung injury, oxygen deprivation, multiorgan damage, critical illness, and often death. Post SARS–CoV–2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection, the fight between the invading virus and the host's immune system would either terminate in recovery, with eradication of the infection and regulation of the immune system; or there would be a continuation of immune attacks even after the virus has been cleared, leading to immune dysregulation and disease. This outcome is chiefly dependent on two factors: (1) the patient's immune response, and (2) sufficiency plus efficiency of the regulator(s). Concerning the first, the present research introduces a framework based on different types of immune responses to SARS–CoV–2 along with known disease examples, and how this relates to varying clinical outcomes and treatment needs for COVID–19 patients. About the second factor of ‘regulator(s)’, part 1 of the manuscript described in depth the regulatory role of progesterone in COVID–19. The present study investigates five immunity patterns and the status of the regulatory hormone progesterone with respect to the two established demographic risk factors for COVID–19 high-severity: male sex, and old age. The study evaluates the status of progesterone as a credible determinant of immune regulation and dysregulation. It duly relates the immunity patterns to clinical outcomes and evinces indications for clinical use of progesterone in COVID–19. It proposes a clear answer to the question: \"why are males and old patients most likely to have critical illness due to COVID–19?\" The study highlights clinical domains for the use of progesterone in COVID–19. Part 2 of this research introduces the concept of immunity patterns and immunity grading. These concepts herewith provided for the clinical course of COVID–19 also apply to other hyperinflammatory conditions. Possible clinical applications of progesterone to treat critically ill COVID–19 patients will open an avenue for hormonal treatments of infections and other immune-related diseases.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100110","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10394821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Evaluation of peroxisome proliferator-activated receptor-gamma (Ppar-γ) and metabolic dysfunction among hypertensive nigerians 尼日利亚高血压患者过氧化物酶体增殖物激活受体γ (Ppar-γ)和代谢功能障碍的评估
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100108
Oloruntoba Ayodele Ekun, Adedamola Oyeniyi Oyekunle, Calyster Oshiomogho Igbadumhe

Background and Aims

Hypertension is gradually becoming a major health burden in Nigeria; the most populous African nation. Often this starts unnoticed, but later, this disorder leads to complications and death if not properly managed. This study assessed the level of peroxisome proliferator-activated receptor-gamma (PPAR-γ), insulin, glucose and lipid profile components in hypertensive Nigerians.

Methods

A total number of four hundred and nineteen volunteers consisting of two hundred and fifteen (215) hypertensive and two hundred and four (204) normotensive participants (of which two hundred and sixty (260) and one hundred and fifty-nine (159) were female and male respectively) participated in this study. Blood pressure of all volunteers was measured and blood samples of the consenting participants were collected in their fasting state and were analyzed for PPAR-γ, insulin, glucose, glycated haemoglobin (HbA1c) and lipid profile using enzyme-linked immunosorbent assay and Cobas C-111 auto-analyzer respectively. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated.

Results

The mean body mass index (BMI) and blood pressure of hypertensive volunteers were higher (P<0.05) than the control. The female participants had higher (p<0.05) BMI and systolic blood pressure when compared with male counterpart. The circulating levels of PPAR-γ were not significantly different (P>0.05) between hypertensive and control volunteers as well as between gender studied. The glucose, insulin, total cholesterol (TC), high density lipoprotein cholesterol (HDL-c) and Low density lipoprotein cholesterol (LDL-c) were higher in hypertensive volunteers (P<0.05). Insulin, HOMA-IR, total cholesterol, triglycerides and HDL-c were significantly raised (p<0.05) in female participants when compared with male. Negative association existed between PPAR-γ and HbA1c (P<0.001), and between PPAR-γ and glucose (P>0.05). Positive association existed between HOMA-IR and HbA1c, HOMA-IR and Glucose (P<0.001), HOMA-IR and Cholesterol (P<0.05).

Conclusion

Hypertensive volunteers demonstrated higher BMI, insulin, glucose, HbA1c, HOMA-IR, and LDL-c all these could precipitate metabolic dysfunction.

背景和目的高血压正逐渐成为尼日利亚的一个主要健康负担;非洲人口最多的国家。通常,这种疾病开始时不被注意,但后来,如果管理不当,这种疾病会导致并发症和死亡。本研究评估了尼日利亚高血压患者过氧化物酶体增殖物激活受体γ (PPAR-γ)、胰岛素、葡萄糖和脂质谱成分的水平。方法共有419名志愿者参加本研究,其中高血压患者215名,正常患者204名,其中女性260名,男性159名,女性260名。测量所有志愿者的血压,并在空腹状态下收集同意参与者的血液样本,分别使用酶联免疫吸附法和Cobas C-111自动分析仪分析PPAR-γ、胰岛素、葡萄糖、糖化血红蛋白(HbA1c)和血脂。计算胰岛素抵抗的稳态模型评估(HOMA-IR)。结果高血压患者的平均体重指数(BMI)和血压均高于对照组(p < 0.05)。与男性参与者相比,女性参与者的BMI和收缩压更高(p < 0.05)。PPAR-γ的循环水平在高血压组和对照组以及性别之间无显著差异(P>0.05)。高血压组血糖、胰岛素、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)均高于对照组(p < 0.05)。与男性相比,女性受试者的胰岛素、HOMA-IR、总胆固醇、甘油三酯和HDL-c显著升高(p < 0.05)。PPAR-γ与HbA1c呈负相关(p < 0.001), PPAR-γ与葡萄糖呈负相关(p < 0.05)。HOMA-IR与HbA1c、HOMA-IR与葡萄糖(P<0.001)、HOMA-IR与胆固醇(P<0.05)呈正相关。结论高血压志愿者BMI、胰岛素、血糖、HbA1c、HOMA-IR、LDL-c均有较高的代谢功能障碍。
{"title":"Evaluation of peroxisome proliferator-activated receptor-gamma (Ppar-γ) and metabolic dysfunction among hypertensive nigerians","authors":"Oloruntoba Ayodele Ekun,&nbsp;Adedamola Oyeniyi Oyekunle,&nbsp;Calyster Oshiomogho Igbadumhe","doi":"10.1016/j.endmts.2021.100108","DOIUrl":"10.1016/j.endmts.2021.100108","url":null,"abstract":"<div><h3>Background and Aims</h3><p>Hypertension is gradually becoming a major health burden in Nigeria; the most populous African nation. Often this starts unnoticed, but later, this disorder leads to complications and death if not properly managed. This study assessed the level of peroxisome proliferator-activated receptor-gamma (PPAR-γ), insulin, glucose and lipid profile components in hypertensive Nigerians.</p></div><div><h3>Methods</h3><p>A total number of four hundred and nineteen volunteers consisting of two hundred and fifteen (215) hypertensive and two hundred and four (204) normotensive participants (of which two hundred and sixty (260) and one hundred and fifty-nine (159) were female and male respectively) participated in this study. Blood pressure of all volunteers was measured and blood samples of the consenting participants were collected in their fasting state and were analyzed for PPAR-γ, insulin, glucose, glycated haemoglobin (HbA1c) and lipid profile using enzyme-linked immunosorbent assay and Cobas C-111 auto-analyzer respectively. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated.</p></div><div><h3>Results</h3><p>The mean body mass index (BMI) and blood pressure of hypertensive volunteers were higher (P&lt;0.05) than the control. The female participants had higher (p&lt;0.05) BMI and systolic blood pressure when compared with male counterpart. <strong>The circulating levels of PPAR-γ were not significantly different (P&gt;0.05) between hypertensive and control volunteers as well as between gender studied.</strong> The glucose, insulin, total cholesterol (TC), high density lipoprotein cholesterol (HDL-c) and Low density lipoprotein cholesterol (LDL-c) were higher in hypertensive volunteers (P&lt;0.05). Insulin, HOMA-IR, total cholesterol, triglycerides and HDL-c were significantly raised (p&lt;0.05) in female participants when compared with male. Negative association existed between PPAR-γ and HbA1c (P&lt;0.001), and between PPAR-γ and glucose (P&gt;0.05). Positive association existed between HOMA-IR and HbA1c, HOMA-IR and Glucose (P&lt;0.001), HOMA-IR and Cholesterol (P&lt;0.05).</p></div><div><h3>Conclusion</h3><p>Hypertensive volunteers demonstrated higher BMI, insulin, glucose, HbA1c, HOMA-IR, and LDL-c all these could precipitate metabolic dysfunction.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666396121000315/pdfft?md5=f386dc26b3a01c185496b0c6df052b43&pid=1-s2.0-S2666396121000315-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"109689196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
In memoriam: Christian Sauter 纪念:克里斯蒂安·索特
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100115
Hans Ruh , Matthias Barton
{"title":"In memoriam: Christian Sauter","authors":"Hans Ruh ,&nbsp;Matthias Barton","doi":"10.1016/j.endmts.2021.100115","DOIUrl":"10.1016/j.endmts.2021.100115","url":null,"abstract":"","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666396121000388/pdfft?md5=b5d32529900d8a10f5302b6c6c163f04&pid=1-s2.0-S2666396121000388-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44980739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use COVID-19和黄体酮:第一部分。SARS-CoV-2、黄体酮及其潜在临床应用
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100109
Shilpa Bhuaptrai Shah

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection is a global medical challenge. Experience based medicines and therapies are being attempted and vaccines are being developed. SARS-CoV-2 exhibits varied patterns of infection and clinical presentations with varied disease outcomes. These attributes are strongly suggestive of some variables that differ among individuals and that affect the course of SARS-CoV-2 infection and symptoms of COVID-19 (Corona Virus Disease of 2019). Sex hormones vary with ageing, between the sexes, among individuals and populations. Sex hormones are known to play a role in immunity and infections. Progesterone is a critical host factor to promote faster recovery following Influenza A virus infection. Anti-inflammatory effects of progesterone are noted. In part 1 of the current study the regulatory role of progesterone for SARS-CoV-2 infection and COVID-19 is analyzed. The role of progesterone at different stages of the SARS CoV-2 infection is investigated with respect to two types of immunity status: immune regulation and immune dysregulation. Progesterone could have various alleviating impacts from SARS-CoV-2 entry till recovery: reversing of hypoxia, stabilizing of blood pressure, controlling thrombosis, balancing electrolytes, reducing the viral load, regulation of immune responses, damage repair, and clearance of debris among others. The present research adds to the available evidence by providing a comprehensive and thorough evaluation of the regulatory role of progesterone in SARS COV-2 infection, COVID-19 pathogenesis, and immune dysregulation. The available evidence has implications for upcoming studies about pathophysiology of COVID-19, as well as the roles of progesterone and other hormones in other infectious diseases.

SARS-CoV-2(严重急性呼吸综合征冠状病毒2)感染是一项全球性的医学挑战。正在尝试以经验为基础的药物和疗法,正在研制疫苗。SARS-CoV-2表现出不同的感染模式和临床表现,并伴有不同的疾病结局。这些特征强烈暗示了一些个体之间存在差异的变量,这些变量会影响SARS-CoV-2感染的过程和COVID-19(2019年冠状病毒病)的症状。性激素随着年龄、性别、个体和种群的变化而变化。众所周知,性激素在免疫和感染中起着重要作用。黄体酮是促进甲型流感病毒感染后更快恢复的关键宿主因子。注意到黄体酮的抗炎作用。本研究第一部分分析了孕激素在SARS-CoV-2感染和COVID-19中的调节作用。研究了孕激素在SARS - CoV-2感染不同阶段对免疫调节和免疫失调两种免疫状态的影响。从SARS-CoV-2进入到恢复,黄体酮可能具有多种缓解作用:逆转缺氧、稳定血压、控制血栓形成、平衡电解质、降低病毒载量、调节免疫反应、修复损伤、清除碎片等。本研究对孕激素在SARS - COV-2感染、COVID-19发病机制和免疫失调中的调节作用进行了全面、彻底的评估,为现有证据提供了补充。现有证据对即将开展的关于COVID-19病理生理学的研究以及黄体酮和其他激素在其他传染病中的作用具有重要意义。
{"title":"COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use","authors":"Shilpa Bhuaptrai Shah","doi":"10.1016/j.endmts.2021.100109","DOIUrl":"10.1016/j.endmts.2021.100109","url":null,"abstract":"<div><p>SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection is a global medical challenge. Experience based medicines and therapies are being attempted and vaccines are being developed. SARS-CoV-2 exhibits varied patterns of infection and clinical presentations with varied disease outcomes. These attributes are strongly suggestive of some variables that differ among individuals and that affect the course of SARS-CoV-2 infection and symptoms of COVID-19 (Corona Virus Disease of 2019). Sex hormones vary with ageing, between the sexes, among individuals and populations. Sex hormones are known to play a role in immunity and infections. Progesterone is a critical host factor to promote faster recovery following Influenza A virus infection. Anti-inflammatory effects of progesterone are noted. In part 1 of the current study the regulatory role of progesterone for SARS-CoV-2 infection and COVID-19 is analyzed. The role of progesterone at different stages of the SARS CoV-2 infection is investigated with respect to two types of immunity status: immune regulation and immune dysregulation. Progesterone could have various alleviating impacts from SARS-CoV-2 entry till recovery: reversing of hypoxia, stabilizing of blood pressure, controlling thrombosis, balancing electrolytes, reducing the viral load, regulation of immune responses, damage repair, and clearance of debris among others. The present research adds to the available evidence by providing a comprehensive and thorough evaluation of the regulatory role of progesterone in SARS COV-2 infection, COVID-19 pathogenesis, and immune dysregulation. The available evidence has implications for upcoming studies about pathophysiology of COVID-19, as well as the roles of progesterone and other hormones in other infectious diseases.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100109","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39326163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Hypoparathyroidism Associated with the DNA Variants in Non-Coding Sequence Region of Calcium-Sensing Receptor 甲状旁腺功能减退与钙敏感受体非编码序列区DNA变异相关
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100106
Qiang Zhang , Li-Jie Zhang , Sha-Sha Yuan , Xiao-Jiang Quan , Bao-Yu Zhang , Dong Zhao

A stable narrow range of extracellular calcium concentration in the blood is essential for life. The calcium-sensing receptor (CaSR), a member of the G protein-coupled receptors family, is required to adjust the set point of blood extracellular calcium concentration, thus regulate parathyroid hormone (PTH) secretion and renal calcium excretion. Loss or gain function of CaSR mutations may result in either hyper- or hypocalcaemia. The CaSR activating mutations increase its sensitivity to extracellular ionized calcium (Ca2+). As consequence, PTH synthesis and secretion are suppressed continuously at normal ionized calcium concentrations. Patients display hypocalcaemia, hyperphosphatemia and lower levels of PTH. Urinary calcium excretion is increased due to the decreased circulating inappropriately PTH level and the activation of the renal tubular CaSR. Therefore, CaSR becomes a good potential clinical therapeutic target for hypoparathyroidism treatment. In order to define new drugs and improve medical management of hypoparathyroidism patients, this study attempts to identify new CaSR variants and analyse in detail the functional change of these CaSR variants, thus better understand the molecular mechanism involved. The study is based on collected hypoparathyroidism patients in our clinical site. In the study we enrolled in 10 patients, obtained all their clinical results and DNA results from seven patients. Our results indicated that the effect of serum intact PTH level correlated to change of serum Ca2+ and phosphate level. The CaSR carrying newly identified DNA variants displayed strong phosphorylation of phospholipase C and mitogen-activated protein kinases. Although the size of clinical cases need to be accumulated, current cases have showed a tendency that the identified multiple DNA variants in CaSR gene revealed an effect on the diagnostic criterion of the hypocalcaemic syndrome. It is undeniable that our research has certain limitations. So far, we tested several DNA variants at the same time, further functional examination for individual DNA variant would largely help to be better understand the mechanisms of CaSR regulation on extracellular calcium concentration.

血液中细胞外钙浓度稳定的窄范围是维持生命所必需的。钙敏感受体(calcium-sensing receptor, CaSR)是G蛋白偶联受体家族中的一员,需要调节血液细胞外钙浓度的设定点,从而调节甲状旁腺激素(parathyroid hormone, PTH)的分泌和肾脏钙的排泄。CaSR突变的丧失或获得功能可能导致高或低钙血症。CaSR激活突变增加了其对细胞外离子钙(Ca2+)的敏感性。因此,在正常离子钙浓度下,甲状旁腺激素的合成和分泌持续受到抑制。患者表现为低钙血症、高磷血症和较低水平的甲状旁腺激素。尿钙排泄增加是由于循环中不适当的甲状旁腺激素水平降低和肾小管CaSR的激活。因此,CaSR成为治疗甲状旁腺功能减退症的潜在临床治疗靶点。为了确定新的药物,改善甲状旁腺功能减退患者的医疗管理,本研究试图鉴定新的CaSR变异,并详细分析这些CaSR变异的功能变化,从而更好地了解其分子机制。这项研究是基于收集的甲状旁腺功能减退症患者在我们的临床现场。在这项研究中,我们招募了10名患者,获得了其中7名患者的所有临床结果和DNA结果。我们的结果表明,血清完整PTH水平的影响与血清Ca2+和磷酸盐水平的变化有关。携带新鉴定的DNA变体的CaSR显示出磷脂酶C和丝裂原活化蛋白激酶的强烈磷酸化。虽然临床病例的规模有待积累,但目前的病例已经显示出一种趋势,即发现的CaSR基因的多个DNA变异对低钙血症综合征的诊断标准有影响。不可否认,我们的研究有一定的局限性。到目前为止,我们同时测试了几种DNA变体,进一步对单个DNA变体进行功能检查将有助于更好地理解CaSR调控细胞外钙浓度的机制。
{"title":"Hypoparathyroidism Associated with the DNA Variants in Non-Coding Sequence Region of Calcium-Sensing Receptor","authors":"Qiang Zhang ,&nbsp;Li-Jie Zhang ,&nbsp;Sha-Sha Yuan ,&nbsp;Xiao-Jiang Quan ,&nbsp;Bao-Yu Zhang ,&nbsp;Dong Zhao","doi":"10.1016/j.endmts.2021.100106","DOIUrl":"https://doi.org/10.1016/j.endmts.2021.100106","url":null,"abstract":"<div><p>A stable narrow range of extracellular calcium concentration in the blood is essential for life. The calcium-sensing receptor (CaSR), a member of the G protein-coupled receptors family, is required to adjust the set point of blood extracellular calcium concentration, thus regulate parathyroid hormone (PTH) secretion and renal calcium excretion. Loss or gain function of CaSR mutations may result in either hyper- or hypocalcaemia. The CaSR activating mutations increase its sensitivity to extracellular ionized calcium (Ca<sup>2+</sup>). As consequence, PTH synthesis and secretion are suppressed continuously at normal ionized calcium concentrations. Patients display hypocalcaemia, hyperphosphatemia and lower levels of PTH. Urinary calcium excretion is increased due to the decreased circulating inappropriately PTH level and the activation of the renal tubular CaSR. Therefore, CaSR becomes a good potential clinical therapeutic target for hypoparathyroidism treatment. In order to define new drugs and improve medical management of hypoparathyroidism patients, this study attempts to identify new CaSR variants and analyse in detail the functional change of these CaSR variants, thus better understand the molecular mechanism involved. The study is based on collected hypoparathyroidism patients in our clinical site. In the study we enrolled in 10 patients, obtained all their clinical results and DNA results from seven patients. Our results indicated that the effect of serum intact PTH level correlated to change of serum Ca<sup>2+</sup> and phosphate level. The CaSR carrying newly identified DNA variants displayed strong phosphorylation of phospholipase C and mitogen-activated protein kinases. Although the size of clinical cases need to be accumulated, current cases have showed a tendency that the identified multiple DNA variants in CaSR gene revealed an effect on the diagnostic criterion of the hypocalcaemic syndrome. It is undeniable that our research has certain limitations. So far, we tested several DNA variants at the same time, further functional examination for individual DNA variant would largely help to be better understand the mechanisms of CaSR regulation on extracellular calcium concentration.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100106","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137241022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation impact in metabolic parameters from hypertensive rats 高血压大鼠交感神经张力和下丘脑-垂体-肾上腺(HPA)轴激活对代谢参数的影响
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100112
Larissa Yuri Ishizu, Filipy Borghi, Ana Gabriela Conceição-Vertamatti, Gustavo Trevisan Costa, Luiz Alberto Ramos, Miguel Arcanjo Área, Dora Maria Grassi-Kassisse

Increased activity of the sympathetic nervous system (SNS) may play an important role in the development of hypertension and in adiposity disorders. We aimed to investigate the influence of increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation in metabolic parameters by evaluating the morphometry of isolated adipocytes from different fat pads and energy consumption. Serum levels of catecholamines, HPA hormones, T3 and adipokines were measured in 15-weeks-old Wistar (WIS), Wistar-Kyoto (WKY), Spontaneously Hypertensive Rats (SHR) and WIS treated with NG-nitro-L-arginine methyl ester (L-NAME). L-NAME and SHR showed a reduced adiposity when compared to their controls, which may be related to higher concentrations of T3. However, SHR presented the most evident lipodystrophy, presenting significant changes in the morphometry from isolated adipocytes and the production of adipokines. Thus, our study suggests that endocrine changes in hypertension models may highlight possible therapeutic targets in the treatment of metabolic changes associated with hypertension.

交感神经系统(SNS)活动的增加可能在高血压和肥胖疾病的发展中起重要作用。我们的目的是通过评估不同脂肪垫和能量消耗的离体脂肪细胞的形态测量来研究交感神经张力增加和下丘脑-垂体-肾上腺(HPA)轴激活对代谢参数的影响。用ng -硝基- l -精氨酸甲酯(L-NAME)治疗15周龄Wistar (WIS)、Wistar- kyoto (WKY)、自发性高血压大鼠(SHR)和WIS,测定血清儿茶酚胺、HPA激素、T3和脂肪因子水平。与对照组相比,L-NAME和SHR组的肥胖程度有所降低,这可能与较高浓度的T3有关。然而,SHR表现出最明显的脂肪营养不良,从分离的脂肪细胞形态和脂肪因子的产生中表现出显著的变化。因此,我们的研究表明,高血压模型中的内分泌变化可能在治疗与高血压相关的代谢变化中突出可能的治疗靶点。
{"title":"Increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation impact in metabolic parameters from hypertensive rats","authors":"Larissa Yuri Ishizu,&nbsp;Filipy Borghi,&nbsp;Ana Gabriela Conceição-Vertamatti,&nbsp;Gustavo Trevisan Costa,&nbsp;Luiz Alberto Ramos,&nbsp;Miguel Arcanjo Área,&nbsp;Dora Maria Grassi-Kassisse","doi":"10.1016/j.endmts.2021.100112","DOIUrl":"10.1016/j.endmts.2021.100112","url":null,"abstract":"<div><p>Increased activity of the sympathetic nervous system (SNS) may play an important role in the development of hypertension and in adiposity disorders. We aimed to investigate the influence of increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation in metabolic parameters by evaluating the morphometry of isolated adipocytes from different fat pads and energy consumption. Serum levels of catecholamines, HPA hormones, T3 and adipokines were measured in 15-weeks-old Wistar (WIS), Wistar-Kyoto (WKY), Spontaneously Hypertensive Rats (SHR) and WIS treated with <em>N</em><sup>G</sup>-nitro-L-arginine methyl ester (L-NAME). L-NAME and SHR showed a reduced adiposity when compared to their controls, which may be related to higher concentrations of T3. However, SHR presented the most evident lipodystrophy, presenting significant changes in the morphometry from isolated adipocytes and the production of adipokines. Thus, our study suggests that endocrine changes in hypertension models may highlight possible therapeutic targets in the treatment of metabolic changes associated with hypertension.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100112","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"106721228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrine and Metabolic Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1